Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes
CompletedNAResults postedLast updated 9 April 2026
What this trial tests
NA trial testing CGM in Pregestational Diabetes in 39 participants. Completed in 30 April 2024.
Adults 18 to 50, female only, with Pregestational Diabetes. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants With Hypoglycemia During Postpartum Hospital StayPrimary· Postpartum admission, 2-5 days
glucose values
With postpartum CGM
Group
Value
95% CI
Type I DM
5
Type II DM
2
Without postpartum CGM (point of care glucometer)
Group
Value
95% CI
Type I DM
4
Type II DM
5
Adverse events — posted to ClinicalTrials.gov
Time frame: Patients were monitored from enrollment until hospital discharge postpartum up to 5 days.
Reporting threshold: 5%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07477249 — Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment
· NA
· recruiting
NCT06863337 — Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring
· NA
· recruiting
NCT06883812 — Continuous Glucose Monitoring in Prediabetes With Health Education Videos Among Community Health Workers
· NA
· completed
NCT06586632 — The Steno Free Trial: AID to Adults with New-onset of Type 1 Diabetes
· NA
· not yet recruiting
NCT06226948 — Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases
· NA
· completed
Other University of Iowa trials
Trials by the same sponsor.
NCT07224269 — Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis
· EARLY_PHASE1
· not yet recruiting
NCT07244809 — Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adve
· NA
· recruiting
NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study
· NA
· recruiting
NCT06951594 — Robotic-Assisted Versus Manual Electrode Array Insertion
· NA
· recruiting
NCT06710119 — Effect of Custom Dynamic Orthoses on Forefoot Loading
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Iowa
Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06141941.